The Centromeric Region of Chromosome 7 from MRL Mice (Lmb3) Is an Epistatic Modifier of Fas for Autoimmune Disease Expression

Journal of Immunology

Volumn 172, Issue 5, 2004, Pages 2785-2794

  Kong, Philip L ^a   Morel, Laurence ^b   Croker, Byron P ^b,c   Craft, Joseph ^a,d  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c N FL/S Georgia Vet Health System   (United States)

^d Anlyan Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; FAS ANTIGEN; GENE PRODUCT; PROTEIN LMB3; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIGEN PRESENTING CELL; ARTICLE; AUTOIMMUNE DISEASE; BACKCROSSING; CENTROMERE; CHROMOSOME 7; CONTROLLED STUDY; DISEASE PREDISPOSITION; GENE INTERACTION; GENE LOCUS; GENETIC EPISTASIS; GENETIC RESISTANCE; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; KIDNEY DISEASE; LMB3 GENE; LUPUS ERYTHEMATOSUS; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; PROTEIN MODIFICATION; STRAIN IDENTIFICATION; T LYMPHOCYTE ACTIVATION;

EID: 1342282319     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.172.5.2785     Document Type: Article

References (46)

1. Tan, F. K., and F. C. Arnett. 1998. The genetics of lupus. Curr. Opin. Rheumatol. 10:399.
2. Tsao, B. P. 2002. An update on genetic studies of systemic lupus erythematosus. Curr. Rheumatol. Rep. 4:359.
3. Kelly, J. A., K. L. Moser, and J. B. Harley. 2002. The genetics of systemic lupus erythematosus: putting the pieces together. Genes Immun. 3(Suppl. 1):S7.
4. Wakeland, E. K., K. Liu, R. R. Graham, and T. W. Behrens. 2001. Delineating the genetic basis of systemic lupus erythematosus. Immunity 15:397.
5. Theofilopoulos, A. N., and D. H. Kono. 2002. A genetic analysis of lupus. Allergy 57(Suppl. 72):67.
6. Morel, L., U. H. Rudofsky, J. A. Longmate, J. Schiffenbauer, and E. K. Wakeland. 1994. Polygenic control of susceptibility to murine systemic lupus erythematosus. Immunity 1:219.
7. Mohan, C., L. Morel, P. Yang, H. Watanabe, B. Croker, G. Gilkeson, and E. K. Wakeland. 1999. Genetic dissection of lupus pathogenesis: a recipe for nephrophilic autoantibodies. J. Clin. Invest. 103:1685.
8. Morel, L., B. P. Croker, K. R. Blenman, C. Mohan, G. Huang, G. Gilkeson, and E. K. Wakeland. 2000. Genetic reconstitution of systemic lupus erythematosus immunopathology with polycongenic murine strains. Proc. Natl. Acad. Sci. USA 97:6670.
9. Rozzo, S. J., J. D. Allard, D. Choubey, T. J. Vyse, S. Izui, G. Peltz, and B. L. Kotzin. 2001. Evidence for an interferon-inducible gene, Ifi202, in the susceptibility to systemic lupus. Immunity 15:435.
10. Morel, L., Y. Yu, K. R. Blenman, R. A. Caldwell, and E. K. Wakeland. 1996. Production of congenic mouse strains carrying genomic intervals containing SLE-susceptibility genes derived from the SLE-prone NZM2410 strain. Mamm. Genome 7:335.
11. Boackle, S. A., V. M. Holers, X. Chen, G. Szakonyi, D. R. Karp, E. K. Wakeland, and L. Morel. 2001. Cr2, a candidate gene in the murine Sle1c lupus susceptibility locus, encodes a dysfunctional protein. Immunity 15:775.
12. Watson, M. L., J. K. Rao, G. S. Gilkeson, P. Ruiz, E. M. Eicher, D. S. Pisetsky, A. Matsuzawa, J. M. Rochelle, and M. F. Seldin. 1992. Genetic analysis of MRL-lpr mice: relationship of the Fas apoptosis gene to disease manifestations and renal disease-modifying loci. J. Exp. Med. 176:1645.
13. Vidal, S., D. H. Kono, and A. N. Theofilopoulos. 1998. Loci predisposing to autoimmunity in MRL-Fas lpr and C57BL/6-Fas lpr mice. J. Clin. Invest. 101:696.
14. Mohan, C., Y. Yu, L. Morel, P. Yang, and E. K. Wakeland. 1999. Genetic dissection of Sle pathogenesis: Sle3 on murine chromosome 7 impacts T cell activation, differentiation, and cell death. J. Immunol. 162:6492.
15. Sobel, E. S., L. Morel, R. Baert, C. Mohan, J. Schiffenbauer, and E. K. Wakeland. 2002. Genetic dissection of systemic lupus erythematosus pathogenesis: evidence for functional expression of Sle3/5 by non-T cells. J. Immunol. 169:4025.
16. Wakeland, E. K., L. Morel, C. Mohan, and M. Yui. 1997. Genetic dissection of lupus nephritis in murine models of SLE. J. Clin. Immunol. 17:272.
17. Yin, Z., G. Bahtiyar, N. Zhang, L. Liu, P. Zhu, M. E. Robert, J. McNiff. M. P. Madaio, and J. Craft. 2002. IL-10 regulates murine lupus. J. Immunol. 169:2148.
18. Mohan, C., S. Adams, V. Stanik, and S. K. Datta. 1993. Nucleosome: a major immunogen for pathogenic autoantibody-inducing T cells of lupus. J. Exp. Med. 177:1367.
19. Fatenejad, S., M. J. Mamula, and J. Craft. 1993. Role of intermolecular/intrastructural B- and T-cell determinants in the diversification of autoantibodies to ribonucleoprotein particles. Proc. Natl. Acad. Sci. USA 90:12010.
20. - cell production in vitro. Br. J. Haematol. 98:528.
21. Watanabe-Fukunaga, R., C. I. Brannan, N. G. Copeland, N. A. Jenkins, and S. Nagata. 1992. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356:314.
22. Cohen, P. L., and R. A. Eisenberg. 1991. Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. Annu. Rev. Immunol. 9:243.
23. Adachi, M., S. Suematsu, T. Suda, D. Watanabe, H. Fukuyama, J. Ogasawara, T. Tanaka, N. Yoshida, and S. Nagata. 1996. Enhanced and accelerated lymphoproliferation in Fas-null mice. Proc. Natl. Acad. Sci. USA 93:2131.
24. Izui, S., V. E. Kelley, K. Masuda, H. Yoshida, J. B. Roths, and E. D. Murphy. 1984. Induction of various autoantibodies by mutant gene lpr in several strains of mice. J. Immunol. 133:227.
25. Chan, O. T., M. P. Madaio, and M. J. Shlomchik. 1999. B cells are required for lupus nephritis in the polygenic, Fas-intact MRL model of systemic autoimmunity. J. Immunol. 163:3592.
26. Fatenejad, S., S. L. Peng, O. Disorbo, and J. Craft. 1998. Central T cell tolerance in lupus-prone mice: influence of autoimmune background and the lpr mutation. J. Immunol. 161:6427.
27. Peng, S. L., M. P. Madaio, and J. Craft. 1996. Systemic autoimmunity in LG/J mice. Immunol. Lett. 53:153.
28. Theofilopoulos, A. N., P. J. McConahey, S. Izui, R. A. Eisenberg, A. B. Pereira, and W. D. Creighton. 1980. A comparative immunologic analysis of several murine strains with autoimmune manifestations. Clin. Immunol. Immumopathol. 15:258.
29. Dutton, R. W., L. M. Bradley, and S. L. Swain. 1998. T cell memory. Annu. Rev. Immunol. 16:201.
30. Tough, D. F., and J. Sprent. 1994. Turnover of naive- and memory-phenotype T cells. J. Exp. Med. 179:1127.
31. Reap, E. A., E. S. Sobel, P. L. Cohen, and R. A. Eisenberg. 1993. Conventional B cells, not B-1 cells, are responsible for producing autoantibodies in lpr mice. J. Exp. Med. 177:69.
32. + T cells from lupus-prone mice are hyperresponsive to T cell receptor engagement with low and high affinity peptide antigens: a model to explain spontaneous T cell activation in lupus. J. Exp. Med. 193:329.
33. + T cells from lupus-prone mice avoid antigen-specific tolerance induction in vivo. J. Immunol. 170:741.
34. Kelley, V. E., and J. B. Roths. 1985. Interaction of mutant lpr gene with background strain influences renal disease. Clin. Immunol. Immunopathol. 37:220.
35. 2-microglobulin-deficient mice are protected from hypergammaglobulinemia and have defective antibody responses because of increased IgG catabolism. J. Immunol. 159:4781.
36. Lefkowith, J. B., and G. S. Gilkeson. 1996. Nephritogenic autoantibodies in lupus: current concepts and continuing controversies. Arthritis Rheum. 39:894.
37. Waters, S. T., S. M. Fu, F. Gaskin, U. S. Deshmukh, S. S. Sung, C. C. Kannapell, K. S. Tung, S. B. McEwen, and M. McDuffie. 2001. NZM2328: a new mouse model of systemic lupus erythematosus with unique genetic susceptibility loci. Clin. Immunol. 100:372.
38. Chan, O. T., L. G. Hannum, A. M. Haberman, M. P. Madaio, and M. J. Shlomchik. 1999. A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus. J. Exp. Med. 189:1639.
39. Maldonado, M. A., R. A. Eisenberg, E. Roper, P. L. Cohen, and B. L. Kotzin. 1995. Greatly reduced lymphoproliferation in lpr mice lacking major histocompatibility complex class I. J. Exp. Med. 181:641.
40. Pestano, G. A., Y. Zhou, L. A. Trimble, J. Daley, G. F. Weber, and H. Cantor. 1999. Inactivation of misselected CD8 T cells by CD8 gene methylation and cell death. Science 284:1187.
41. Ueda, H., J. M. Howson, L. Esposito, J. Heward, H. Snook, G. Chamberlain, D. B. Rainbow, K. M. Hunter, A. N. Smith, G. Di Genova, et al. 2003. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 423:506.
42. Shi, X., C. Xie, D. Kreska, J. A. Richardson, and C. Mohan. 2002. Genetic dissection of SLE: SLE1 and FAS impact alternate pathways leading to lymphoproliferative autoimmunity. J. Exp. Med. 196:281.
43. Croker, B. P., G. Gilkeson, and L. Morel. 2003. Genetic interactions between susceptibility locus reveal epistatic pathogenic networks in murine lupus. Genes Immun. 4:575.
44. Theofilopoulos, A. N., and D. H. Kono. 1999. The genes of systemic autoimmunity. Proc. Assoc. Am. Physicians 111:228.
45. + memory T cells from the spleen lack MEL-14, the lymph node homing receptor. J. Immunol. 148:324.
46. Loder, F., B. Mutschler, R. J. Ray, C. J. Paige, P. Sideras, R. Torres, M. C. Lamers, and R. Carsetti. 1999. B cell development in the spleen takes place in discrete steps and is determined by the quality of B cell receptor-derived signals. J. Exp. Med. 190:75.